Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.06 USD | -1.42% | -3.06% | 0.00% |
04-15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
04-15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
468M | - | - | - | - | - | |
121B | ||||||
112B | ||||||
22.57B | - | |||||
20.82B | - | |||||
16.3B | - |